Chronic Disease
Featured Topics
Lead story
Other featured articles
-
Researchers Link Educational Attainment to Reduced Burden of Serious Mental Illness
A new USC Schaeffer Center study shows the return on investing in improving educational attainment for those diagnosed with serious mental illness by age twenty-five, projecting positive impacts on health and economic outcomes.
Posted in -
A New Way to Pay for Innovative Drugs, Provide Universal Access and Not Break the Bank
Neeraj Sood penned an analysis of Louisiana's new path to curing hepatitis C among its Medicaid and prison populations. It is the first state to implement a solution proposed by Sood in a National Academies of Sciences consensus report and in a leading medical journal.
Posted in -
NIH Awards USC School of Pharmacy, Price School of Public Policy 5-Year Grant to Support Minority Aging Research in Schaeffer Center
The $2.7 million award funds scholars pursuing research in health disparities in aging with an emphasis on Alzheimer’s disease.
Posted in -
Mortality Risk, Insurance, and the Value of Life
People with shorter life expectancies place more value on increases in survival than people who anticipate longer life spans.
About this section
Chronic diseases are among the most preventable and costliest conditions, consuming the overwhelming majority of Medicare resources. The Schaeffer Center assembles leading minds from across disciplines to address this challenge, striving to simplify labyrinthine systems of care and promote healthier outcomes.
Our Experts On Chronic Disease
Our Work In Chronic Disease
-
The Association of Multiple Anti-Hypertensive Medication Classes with Alzheimer’s Disease Incidence Across Sex, Race, and Ethnicity
The researchers find hypertension management treatments that include RAS-acting ARBs may, in addition to lowering blood pressure, reduce AD risk, particularly for white and black women and white men.
-
Some Blood Pressure Medications May Reduce Risk of Alzheimer’s, But Not For All Populations
Certain antihypertensive medications may prevent the onset of the disease, but only among black and white women and white men.
-
Proposition 3 Could Provide New Resources for Utahns with Diabetes
An overlooked factor in the debate over Proposition 3 is the impact that an expansion of Utah’s Medicaid program would have on the state’s diabetes epidemic, argues Rebecca Myerson in an op-ed in the Salt Lake Tribune.
Categorized in -
Racial and Ethnic Differences in Trends in Dementia Prevalence and Risk Factors in the United States
The researchers find disparities in dementia prevalence declined between blacks and whites and increased between Hispanics and whites.
-
Mortality Risk, Insurance, and the Value of Life
In a working paper submitted to the National Bureau of Economic Research, Darius Lakdawalla found mortality improvement may be worth more, not less, to patients facing shorter lives.
Categorized in -
Medicaid Expansion Increases Access to Diabetes Medications
States that expanded Medicaid saw a 40 percent increase in prescription fills for common diabetes drugs in 2014-2015 according to the study in Health Affairs.
Categorized in